Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. 1990

D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
Battelle Medical Technology and Policy Research Center, Washington, D.C. 20024.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D012017 Referral and Consultation The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide. Consultation,Gatekeepers, Health Service,Hospital Referral,Second Opinion,Consultation and Referral,Health Service Gatekeepers,Hospital Referrals,Referral,Referral, Hospital,Referrals, Hospital,Consultations,Gatekeeper, Health Service,Health Service Gatekeeper,Opinion, Second,Opinions, Second,Referrals,Second Opinions
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003156 Community Mental Health Services Diagnostic, therapeutic and preventive mental health services provided for individuals in the community. Community Mental Health Service,Mental Health Services, Community,Assertive Community Treatment,Health Services, Community Mental,Services, Community Mental Health,Services, Mental Health Community,Community Treatment, Assertive,Treatment, Assertive Community
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
January 1997, European psychiatry : the journal of the Association of European Psychiatrists,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
November 1993, The American journal of psychiatry,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
July 1999, Biological psychiatry,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
January 1997, The Journal of neuropsychiatry and clinical neurosciences,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
January 1998, Psychiatry research,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
December 2007, Pakistan journal of biological sciences : PJBS,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
April 2005, Indian journal of psychiatry,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
January 1989, Psychopharmacology,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
March 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,
D A Revicki, and B R Luce, and J M Weschler, and R E Brown, and M A Adler
July 1999, Hospital medicine (London, England : 1998),
Copied contents to your clipboard!